These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32931001)

  • 1. Ultrastructural intestinal mucosa change after prolonged inhibition of gastric acid secretion by omeprazole in male rats.
    Chamniansawat S; Kampuang N; Suksridechacin N; Thongon N
    Anat Sci Int; 2021 Jan; 96(1):142-156. PubMed ID: 32931001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of prolonged omeprazole administration on segmental intestinal Mg
    Suksridechacin N; Kulwong P; Chamniansawat S; Thongon N
    World J Gastroenterol; 2020 Mar; 26(11):1142-1155. PubMed ID: 32231419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe hypomagnesemia and hypoparathyroidism induced by omeprazole.
    Rodríguez Ortega P; Rebollo Pérez I; Laínez López M; Roldán Mayorga E; Hernández Lavado R; Creagh Cerquera R
    Endocrinol Nutr; 2013 Mar; 60(3):156-7. PubMed ID: 22627012
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole suppressed plasma magnesium level and duodenal magnesium absorption in male Sprague-Dawley rats.
    Thongon N; Penguy J; Kulwong S; Khongmueang K; Thongma M
    Pflugers Arch; 2016 Nov; 468(11-12):1809-1821. PubMed ID: 27866273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Drugs affecting serum magnesium concentration].
    Kawamura Y
    Clin Calcium; 2012 Aug; 22(8):1211-6. PubMed ID: 22846357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton pump inhibitors are not the key for therapying non-steroidal anti-inflammatory drugs-induced small intestinal injury.
    Zhang S; Chao GQ; Lu B
    Rheumatol Int; 2013 Oct; 33(10):2513-21. PubMed ID: 23604681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hypomagnesemia induced by proton pump inhibitors, diarrhea, and lactose intolerance].
    Cano Megías M; Alvarez Santirso R; Iglesias Lozano P; Carrasco De La Fuente M; Pérez López G
    Endocrinol Nutr; 2011 Dec; 58(10):550-4. PubMed ID: 21764396
    [No Abstract]   [Full Text] [Related]  

  • 9. Proton pump inhibitors and hypomagnesemia in polymorbid elderly adults.
    Pastorino A; Greppi F; Bergamo D; Versino E; Bo M; Pezzilli MS; Furno E; Rrodhe S; Isaia G
    J Am Geriatr Soc; 2015 Jan; 63(1):179-80. PubMed ID: 25597570
    [No Abstract]   [Full Text] [Related]  

  • 10. Recent safety concerns with proton pump inhibitors.
    Chen J; Yuan YC; Leontiadis GI; Howden CW
    J Clin Gastroenterol; 2012 Feb; 46(2):93-114. PubMed ID: 22227731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In brief: PPI's and hypomagnesemia.
    Med Lett Drugs Ther; 2011 Apr; 53(1361):25. PubMed ID: 21464802
    [No Abstract]   [Full Text] [Related]  

  • 13. [Review: UPDATE on magnesium metabolism].
    Fatuzzo P; Zanoli L; Scollo V; Portale G; Gaudio A; Pani A; Granata A
    G Ital Nefrol; 2016; 33(6):. PubMed ID: 28134397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.
    McColl KE; Gillen D
    Gastroenterology; 2009 Jul; 137(1):20-2. PubMed ID: 19482105
    [No Abstract]   [Full Text] [Related]  

  • 15. Ingestion of guar-gum hydrolysate partially restores calcium absorption in the large intestine lowered by suppression of gastric acid secretion in rats.
    Hara H; Suzuki T; Kasai T; Aoyama Y; Ohta A
    Br J Nutr; 1999 Apr; 81(4):315-21. PubMed ID: 10999019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proton pump inhibitors and hospitalization with hypomagnesemia: a population-based case-control study.
    Zipursky J; Macdonald EM; Hollands S; Gomes T; Mamdani MM; Paterson JM; Lathia N; Juurlink DN
    PLoS Med; 2014 Sep; 11(9):e1001736. PubMed ID: 25268962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole- and esomeprazole-associated hypomagnesaemia: data mining of the public version of the FDA Adverse Event Reporting System.
    Tamura T; Sakaeda T; Kadoyama K; Okuno Y
    Int J Med Sci; 2012; 9(5):322-6. PubMed ID: 22745572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protective effect of
    Yoshihara T; Oikawa Y; Kato T; Kessoku T; Kobayashi T; Kato S; Misawa N; Ashikari K; Fuyuki A; Ohkubo H; Higurashi T; Tateishi Y; Tanaka Y; Nakajima S; Ohno H; Wada K; Nakajima A
    Gut Microbes; 2020 Sep; 11(5):1385-1404. PubMed ID: 32515658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A 78-year-old female patient with dizziness, apraxia and seizure under proton pump inhibitor therapy].
    Piezzi V; Kullak-Ublick GA; Glisenti P
    Internist (Berl); 2014 Feb; 55(2):199-205. PubMed ID: 24419536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric acid blockade with omeprazole promotes gastric carcinogenesis induced by duodenogastric reflux.
    Wetscher GJ; Hinder RA; Smyrk T; Perdikis G; Adrian TE; Profanter C
    Dig Dis Sci; 1999 Jun; 44(6):1132-5. PubMed ID: 10389684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.